The immunocompromised patient: guidelines for the clinical approach.
D000380:Agranulocytosis / Q000175:diagnosis / Q000209:etiology; D000890:Anti-Infective Agents / Q000627:therapeutic use; D003428:Cross Infection / Q000209:etiology; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007239:Infections / Q000209:etiology* / Q000628:therapy; D009369:Neoplasms / Q000188:drug therapy
D000890:Anti-Infective Agents; D007166:Immunosuppressive Agents